Literature DB >> 18548200

Transcription factor TAFII250 phosphorylates the acidic domain of Mdm2 through recruitment of protein kinase CK2.

Nerea Allende-Vega1, Lynsey McKenzie, David Meek.   

Abstract

Induction and activation of the p53 tumour suppressor protein occurs in response to a number of cellular stresses, including disruption of RNA polymerase II-mediated transcription. Both p53 itself and its principle negative regulator, the E3 ubiquitin ligase Mdm2, are substrates for phosphorylation by the protein kinase CK2 in vitro. CK2 phosphorylates Mdm2 within its central acidic domain, a region that is critical for making a second point of contact with p53 and mediating p53 ubiquitylation and turnover. Additionally, there is evidence that CK2 interacts with, and regulates, both p53 and Mdm2 within the cell but the molecular mechanisms through which CK2-mediated regulation of the p53 response can occur are only poorly understood. Previously, we showed that the basal transcription factor TAFII250, a critical component of TFIID, can interact with Mdm2 and promote the association of the Mdm2 acidic domain with p53. In the present study, we show that immunoprecipitates of TAFII250, either from mammalian cell extracts or from baculovirus-infected cells expressing elevated levels of HA-tagged TAFII250, can phosphorylate Mdm2 in vitro within its acidic domain. We show that CK2 is tightly associated with TAFII250 and is the principal activity responsible for TAFII250-mediated phosphorylation of Mdm2. Our data fit with recent observations that phosphorylation of the acidic domain of Mdm2 stimulates its association with p53 and are consistent with a model in which recruitment of CK2 by TAFII250 may play a contributory role in the maintenance of Mdm2 phosphorylation and function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18548200     DOI: 10.1007/s11010-008-9816-3

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  45 in total

1.  Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53.

Authors:  S Fang; J P Jensen; R L Ludwig; K H Vousden; A M Weissman
Journal:  J Biol Chem       Date:  2000-03-24       Impact factor: 5.157

2.  TAFII250 is a bipartite protein kinase that phosphorylates the base transcription factor RAP74.

Authors:  R Dikstein; S Ruppert; R Tjian
Journal:  Cell       Date:  1996-03-08       Impact factor: 41.582

3.  A DNA damage-induced p53 serine 392 kinase complex contains CK2, hSpt16, and SSRP1.

Authors:  D M Keller; X Zeng; Y Wang; Q H Zhang; M Kapoor; H Shu; R Goodman; G Lozano; Y Zhao; H Lu
Journal:  Mol Cell       Date:  2001-02       Impact factor: 17.970

4.  The MDM2 C-terminal region binds to TAFII250 and is required for MDM2 regulation of the cyclin A promoter.

Authors:  T Léveillard; B Wasylyk
Journal:  J Biol Chem       Date:  1997-12-05       Impact factor: 5.157

5.  Identification of a CK2 phosphorylation site in mdm2.

Authors:  C Götz; S Kartarius; P Scholtes; W Nastainczyk; M Montenarh
Journal:  Eur J Biochem       Date:  1999-12

6.  Defect in the p53-Mdm2 autoregulatory loop resulting from inactivation of TAF(II)250 in cell cycle mutant tsBN462 cells.

Authors:  C Wasylyk; B Wasylyk
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

7.  Phosphorylation of yeast TBP by protein kinase CK2 reduces its specific binding to DNA.

Authors:  E Maldonado; J E Allende
Journal:  FEBS Lett       Date:  1999-01-29       Impact factor: 4.124

8.  Functional analysis of the human TAFII250 N-terminal kinase domain.

Authors:  T O'Brien; R Tjian
Journal:  Mol Cell       Date:  1998-05       Impact factor: 17.970

9.  Activation of a DNA damage checkpoint response in a TAF1-defective cell line.

Authors:  Ann M Buchmann; Jeffrey R Skaar; James A DeCaprio
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

10.  Transcription factor TAFII250 promotes Mdm2-dependent turnover of p53.

Authors:  N Allende-Vega; M K Saville; D W Meek
Journal:  Oncogene       Date:  2007-01-22       Impact factor: 9.867

View more
  3 in total

1.  TAF1 differentially enhances androgen receptor transcriptional activity via its N-terminal kinase and ubiquitin-activating and -conjugating domains.

Authors:  Peyman Tavassoli; Latif A Wafa; Helen Cheng; Amina Zoubeidi; Ladan Fazli; Martin Gleave; Robert Snoek; Paul S Rennie
Journal:  Mol Endocrinol       Date:  2010-02-24

Review 2.  Protein kinase CK2 in health and disease: CK2: a key player in cancer biology.

Authors:  J H Trembley; G Wang; G Unger; J Slaton; K Ahmed
Journal:  Cell Mol Life Sci       Date:  2009-06       Impact factor: 9.261

3.  A Novel Interaction between TFII-I and Mdm2 with a Negative Effect on TFII-I Transcriptional Activity.

Authors:  Kateřina Cetkovská; Hana Šustová; Pavlína Kosztyu; Stjepan Uldrijan
Journal:  PLoS One       Date:  2015-12-11       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.